Xenetic Biosciences, Inc. - 8-K Filing
Xenetic Biosciences entered a Share Exchange Agreement to acquire Santersus AG in an all-stock transaction, with post-transaction ownership expected at ~85% by Santersus shareholders and ~15% by existing Xenetic stockholders. (Items: 1.01 Entry into a Material Definitive Agreement, 3.02 Unregistered Sales of Equity Securities, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $XBIO